AKERO THERAPEUTICS INC (AKRO) Stock Cash Flow
NASDAQ:AKRO - Nasdaq - US00973Y1082 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -269.44M | -252.06M | -151.76M | -112.03M | -100.78M | |||
| Depreciation Amortization | 20.00K | 20.00K | 30.00K | 40.00K | 40.00K | |||
| Change In Working Capital | -13.61M | 3.00M | -6.67M | -4.46M | 9.73M | |||
| Interest Paid | 4.19M | 3.98M | 2.48M | 440.00K | N/A | |||
| Other non cash items | 20.54M | 19.00M | 13.00M | 23.93M | 11.33M | |||
| OPERATING CASH FLOW | -263.00M | -230.00M | -145.00M | -92.52M | -79.68M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -1.00M | N/A | N/A | 0.00 | |||
| Other Investing Activity | -649.00M | -109.00M | -224.00M | -63.83M | 42.28M | |||
| INVESTING CASH FLOW | -650.00M | -110.00M | -224.00M | -63.83M | 42.28M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 10.00M | 15.00M | 9.61M | N/A | |||
| Stock Issued/Repurchased | 476.00M | 437.00M | 339.00M | 246.50M | 1.12M | |||
| Other Financing Activity | -1.15M | -840.00K | -780.00K | -470.00K | -520.00K | |||
| FINANCING CASH FLOW | 475.00M | 446.00M | 353.00M | 255.63M | 600.00K | |||
| CHANGE IN CASH | -438.00M | 106.00M | -16.00M | 99.28M | -36.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -263.00M | -230.00M | -145.00M | -92.52M | -79.68M | |||
| Capital Expenditure | N/A | -1.00M | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -264.00M | -231.00M | -145.00M | -92.52M | -79.68M | |||
All data in USD